Human miRNA miR-675 inhibits DUX4 expression and may be exploited as a potential treatment for Facioscapulohumeral muscular dystrophy
Nizar Y. Saad(Nationwide Children's Hospital), Scott Q. Harper(Nationwide Children's Hospital)
Cited by 56
Related Papers
<i>DUX4</i>, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53‐dependent myopathy in vivo
|Annals of Neurology|2010|245